XML 42 R15.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Derivative warrant liabilities | 12 Months Ended
--- | ---
Mar. 31, 2024
Derivative warrant liabilities |
Derivative warrant liabilities | 10. Derivative warrant liabilities Prior to the RTO Transaction, NCAC had two classes of warrants outstanding, which were assumed by the Company upon completion of the RTO Transaction. Public Warrants: which had resulted from NCAC’s initial public offering (the “NCAC IPO”) and entitled to registration on the Form F-4 filed in connection with the RTO Transaction. These warrants were listed on Nasdaq Capital Market under the symbol “PBMWW”. Private Warrants: which had resulted from NCAC’s private placement prior to the NCAC IPO. As at the Closing Date and March 31, 2024, there were 13,070,000 warrants issued and outstanding, comprised of 12,500,000 Public Warrants and 570,000 Private Warrants. Each warrant is exercisable to purchase one common share at a price of $11.50 per share. As a result of the potential cashless exercise feature included within the indenture of the warrants, the Company has classified the warrants as a liability measured at fair value through profit or loss as they failed to meet the “fixed-for-fixed” requirements prescribed by IAS 32 – Financial Instruments: presentation. Since the Public Warrants are traded on Nasdaq, their price is observable. The Company valued the Public Warrants using the closing price of PBMWW to measure their fair value. The Company utilizes a Black-Scholes options valuation model to value the private warrants at each reporting period, with changes in fair value recognized in the statement of net loss and comprehensive loss. The estimated fair value of the warrant liability is determined using Level 2 inputs. Inherent in a Black-Scholes pricing model are assumptions related to expected volatility of the Public Warrants, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on industry historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 2 fair value measurements at March 31, 2024: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | Warrant Inputs at | ​ | Warrant Inputs at |
​ | ​ | January 25, 2024 | ​ | March 31, 2024 | ​
Share price |  | 4.79 | ​ | 1.14 | ​
Expected dividend yield |  | Nil | ​ | Nil | ​
Exercise price |  | 11.50 | ​ | 11.50 | ​
Risk-free interest rate |  | 4.01 | % | 4.21 | %
Expected life |  | 5.00 | ​ | 5.00 | ​
Expected volatility |  | 17.67 | % | 59.98 | %
Expiry date | ​ | January 25, 2029 | ​ | January 25, 2029 | ​
​ At March 31, 2024 the fair value of the Public and Private Warrants was $875,000 ($0.07/warrant) (January 25, 2024 - $568,750) and $26,608 ($0.4668/warrant) (January 25, 2024 - $26,608), respectively. A fair value loss of $306,250 was recognized on the statement of net loss and comprehensive loss. Warrant transactions and the number of warrants outstanding are summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Public Warrants | ​ | Private Warrants
​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | Weighted
​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | ​ | Exercise | ​ | Number of | ​ | ​ | Exercise
​ |  | Warrants |  | ​ | Price |  | Warrants |  | ​ | Price
Balance, March 31, 2023 | ​ | — | ​ | $ | — | ​ | — | ​ | $ | —
Issued | ​ | 12,500,000 | ​ | ​ | 11.50 | ​ | 570,000 | ​ | ​ | 11.50
Balance, March 31, 2024 | ​ | 12,500,000 | ​ | $ | 11.50 | ​ | 570,000 | ​ | $ | 11.50
​ The following warrants were outstanding and exercisable at March 31, 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Number of | ​ | Number of
​ | ​ | ​ | ​ | ​ | Exercise | ​ | Warrants | ​ | Warrants
Issue Date |  | Expiry Date |  | ​ | Price |  | Outstanding |  | Exercisable
January 25, 2024 | ​ | January 25, 2029 | ​ | $ | 11.50 | ​ | 13,070,000 | ​ | 13,070,000
Balance, March 31, 2024 | ​ | ​ | ​ | $ | 11.50 | ​ | 13,070,000 | ​ | 13,070,000
​

X
- Definition The disclosure of derivative financial instruments. [Refer: Derivatives [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pbm_DerivativeWarrantLiabilitiesAbstract
Namespace Prefix: | pbm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration